Monday, November 12, 2018
For nearly two decades, the University of Illinois at Chicago has touted child psychiatrist Mani Pavuluri as one of its stars: She founded a clinic to treat children with bipolar disorder and secured millions of dollars in federal funding to help unlock the mysteries of the disease. Then she violated research rules by testing the powerful drug lithium on children younger than 13 although she was told not to, failed to properly alert parents of the study's risks and falsified data to cover up the misconduct. In December, the university quietly paid a severe penalty for Pavuluri's misconduct and its own lax oversight, after the National Institute of Mental Health demanded the public institution repay all $3.1 million it had received for Pavuluri's study. NIMH said she had "increased risk to the study subjects" and made any outcomes scientifically meaningless.
Dr. Pavuluri was forced to resign in disgrace but kept her GlaxoSmithKline dollars. Entire hospital programs are Pharma funded. Harvard child psychiatrist Joseph "Risperdal" Biederman approached Johnson & Johnson with a money-making scheme called the Johnson & Johnson Center for the Study of Pediatric Psychopathology at Massachusetts General Hospital to "move forward the commercial goals of J. & J." and "support the safety and effectiveness of Risperdal in this age group.
Under Trump, pharma operative Scott Gottlieb now heads the FDA and former Eli Lilly lobbyist Alex Azar now heads Health and Human Services in a clear message that government officials with Pharma ties are fine.
Admin's note: Participants in this discussion must follow the site's moderation policy. Profanity will be filtered. Abusive conduct is not allowed.